Laureate Institute for Brain Research   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Tulsa OK United States (2009)

Organization Overview

First Clinical Trial
2011
NCT01429272
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Laureate Institute for Brain Research | Laureate Institute for Brain Research, Inc.